SCHEMBL6408766

SCHEMBL6408766

COc1ccc(C(OCC2CC2C(=O)OC2CC(C)CCC2C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 4/20 0.44
HCRTR1 O43613 1/20 0.44
GLA P06280 1/20 0.44
IDE P14735 1/20 0.44
XBP1 P17861 1/20 0.44
TRPV1 Q8NER1 2/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 2/20 0.42
MITF O75030 2/20 0.42
HTT P42858 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP19A1 P11511 2/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6473933 1.00 MAPK1 (0.46) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6407542 0.97 ALDH1A1 (0.46) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6413599 0.93 ALDH1A1 (0.49) MAPK1ALDH1A1MAPTNPSR1HPGD
SCHEMBL6406774 0.88 MAPK1 (0.45) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6407075 0.88 MAPK1 (0.45) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6407554 0.87 MAPK1 (0.44) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6408824 0.87 MAPK1 (0.44) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6408275 0.83 TRPV1 (0.45) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6412548 0.83 TRPV1 (0.45) MAPK1ALDH1A1MAPTNPSR1HCRTR1
SCHEMBL6474528 0.81 MAPK1 (0.47) MAPK1ALDH1A1MAPTNPSR1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 MAPK1 1510/4885ALDH1A1 601/4885MAPT 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.